These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28329033)

  • 1. Quantitative Versus Qualitative Use of Lyme Enzyme-Linked Immunosorbent Assay.
    Naktin JP
    Clin Infect Dis; 2017 Apr; 64(8):1144. PubMed ID: 28329033
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Naktin.
    Uhde M; Ajamian M; Wormser GP; Marques AR; Alaedini A
    Clin Infect Dis; 2017 Apr; 64(8):1145-1146. PubMed ID: 28329306
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.
    Uhde M; Ajamian M; Li X; Wormser GP; Marques A; Alaedini A
    Clin Infect Dis; 2016 Dec; 63(11):1399-1404. PubMed ID: 27585799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal-linked Immunosorbent Assay (MeLISA): the Enzyme-Free Alternative to ELISA for Biomarker Detection in Serum.
    Yu RJ; Ma W; Liu XY; Jin HY; Han HX; Wang HY; Tian H; Long YT
    Theranostics; 2016; 6(10):1732-9. PubMed ID: 27446504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease.
    Fawcett PT; Gibney KM; Rose CD; Klein JD; Doughty RA
    J Rheumatol; 1991 May; 18(5):705-8. PubMed ID: 1713972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate Quantification of Disease Markers in Human Serum Using Iron Oxide Nanoparticle-linked Immunosorbent Assay.
    Zhang L; Tong S; Zhou J; Bao G
    Theranostics; 2016; 6(9):1353-61. PubMed ID: 27375784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of elevated C-reactive protein and serum amyloid A levels in IgG4-related disease: comment on the article by Perugino et al.
    Karim AF; Eurelings LEM; van Hagen PM; van Laar JAM
    Arthritis Rheumatol; 2018 Feb; 70(2):317-318. PubMed ID: 29088583
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for Lyme disease in hospitalized psychiatric patients: prospective serosurvey in an endemic area.
    Nadelman RB; Herman E; Wormser GP
    Mt Sinai J Med; 1997 Nov; 64(6):409-12. PubMed ID: 9364837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive and accurate detection of C-reactive protein by CdSe/ZnS quantum dot-based fluorescence-linked immunosorbent assay.
    Lv Y; Wu R; Feng K; Li J; Mao Q; Yuan H; Shen H; Chai X; Li LS
    J Nanobiotechnology; 2017 May; 15(1):35. PubMed ID: 28464873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in clinical tests and the pathophysiological study of collagen diseases--erythrocyte sedimentation, C-reactive protein and serum amyloid A protein].
    Sasaki T; Tsukamoto S
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2390-5. PubMed ID: 9922656
    [No Abstract]   [Full Text] [Related]  

  • 11. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnostic tests for Lyme disease.
    Wilkinson HW
    Yale J Biol Med; 1984; 57(4):567-72. PubMed ID: 6393608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Positive Predictive Value of Lyme Elisa for the Diagnosis of Lyme Disease in Children.
    Lipsett SC; Pollock NR; Branda JA; Gordon CD; Gordon CR; Lantos PM; Nigrovic LE
    Pediatr Infect Dis J; 2015 Nov; 34(11):1260-2. PubMed ID: 26222064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bascom Palmer Eye Institute Lyme/syphilis survey.
    Smith JL; Crumpton BC; Hummer J
    J Clin Neuroophthalmol; 1990 Dec; 10(4):255-60. PubMed ID: 2150843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the diagnosis of Lyme disease.
    van Dam AP
    Expert Rev Mol Diagn; 2001 Nov; 1(4):413-27. PubMed ID: 11901856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness.
    Yamada T
    Clin Chem Lab Med; 1999 Apr; 37(4):381-8. PubMed ID: 10369107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study of C-reactive protein in the diagnosis and monitoring of Lyme disease.
    Chan SS; Wong YC; Hodgkiss IJ
    Biomed Environ Sci; 1996 Dec; 9(4):424-9. PubMed ID: 8988812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum.
    Ledue TB; Weiner DL; Sipe JD; Poulin SE; Collins MF; Rifai N
    Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():745-53. PubMed ID: 9838988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease.
    Rose CD; Fawcett PT; Singsen BH; Dubbs SB; Doughty RA
    Pediatrics; 1991 Sep; 88(3):465-70. PubMed ID: 1881724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.
    Leeflang MM; Ang CW; Berkhout J; Bijlmer HA; Van Bortel W; Brandenburg AH; Van Burgel ND; Van Dam AP; Dessau RB; Fingerle V; Hovius JW; Jaulhac B; Meijer B; Van Pelt W; Schellekens JF; Spijker R; Stelma FF; Stanek G; Verduyn-Lunel F; Zeller H; Sprong H
    BMC Infect Dis; 2016 Mar; 16():140. PubMed ID: 27013465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.